Ting-Hui Jiang, Xian-Jun Sun, Yue Chen, Hui-Qin Cheng, Shi-Ming Fang, Hao-Sheng Jiang, Yan Cao, Bing-Yan Liu, Shao-Qiu Wu, Ai-Wu Mao
Journal: World journal of gastroenterology 2015;21(8):2467-74
PMID: 25741156
AIM
To investigate the efficacy and safety of percutaneous needle decompression in the treatment of malignant small bowel obstruction (MSBO).
METHODS
A prospective analysis of the clinical data of 52 MSBO patients undergoing percutaneous needle decompression was performed.
RESULTS
Percutaneous needle decompression was successful in all 52 patients. Statistically significant differences were observed in symptoms such as vomiting, abdominal distension and abdominal pain before and after treatment (81.6% vs 26.5%, 100% vs 8.2%, and 85.7% vs 46.9%, respectively; all P < 0.05). The overall significantly improved rate was 19.2% (11/52) and the response rate was 94.2% (49/52) using decompression combined with nasal tube placement, local arterial infusion of chemotherapy and nutritional support. During the one-month follow-up period, puncture-related complications were acceptable.
CONCLUSION
Percutaneous needle intestinal decompression is a safe and effective palliative treatment for MSBO.
Full Text Sources:
Medical:
Other Literature Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.